These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 6283602)

  • 1. Cytomegalovirus infection in transplant patients.
    Betts RF
    Prog Med Virol; 1982; 28():44-64. PubMed ID: 6283602
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients.
    Pollard RB; Merigan TC
    Transplant Proc; 1978 Mar; 10(1):241-5. PubMed ID: 205021
    [No Abstract]   [Full Text] [Related]  

  • 3. The usefulness of hyperimmune globulin for treatment of overt cytomegalovirus infection in allograft recipients.
    Rancewicz Z; Halama G; Smogorzewski M; Durlik M; Rowinska D; Lao M; Juskowa J; Wyzgal J
    Transplant Proc; 1990 Aug; 22(4):1818-9. PubMed ID: 2167538
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
    Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of infection and acute rejection after cytomegalovirus immune globulin prophylaxis in renal transplantation.
    Basadonna G; Feria A; Perez R; Klein H; Sturges M; Colquhoun S
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):52-3. PubMed ID: 7940976
    [No Abstract]   [Full Text] [Related]  

  • 6. Issues concerning the use of intravenous immunoglobulins for the immunoprophylaxis of cytomegalovirus infections in allogeneic bone marrow transplant recipients.
    Emanuel D
    Monogr Allergy; 1988; 23():216-24. PubMed ID: 2838745
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of latent viruses following bone marrow transplantation.
    Rinaldo CR; Hirsch MS; Black PH
    Transplant Proc; 1976 Dec; 8(4):669-72. PubMed ID: 11595
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of cytomegalovirus disease in transplant recipients.
    Pidgeon GB; Bailey RR
    N Z Med J; 1993 Nov; 106(967):468-9. PubMed ID: 8233192
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent.
    Kapoor N; Copelan EA; Tutschka PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3095-6. PubMed ID: 2539686
    [No Abstract]   [Full Text] [Related]  

  • 10. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection.
    Rand KH; Pollard RB; Merigan TC
    N Engl J Med; 1978 Apr; 298(17):951-3. PubMed ID: 205784
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus infection and kidney graft survival.
    Spencer ES; Fjeldborg O; Andersen HK
    Scand J Urol Nephrol Suppl; 1981; 64():128-31. PubMed ID: 6293049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of CMV infection in bone marrow transplant recipients by hyperimmune CMV gamma-globulin.
    Condie RM; O'Reilly RJ
    Dev Biol Stand; 1982; 52():501-13. PubMed ID: 6299859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections in bone marrow transplant recipients in south India--a post-mortem study.
    Ramani P; Krishnaswami H; Srivastava A; Dennison D; Chandy M
    J Trop Med Hyg; 1994 Dec; 97(6):354-6. PubMed ID: 7966537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the efficacy of cytomegalovirus immune globulin in the prophylaxis of CMV disease in renal transplant recipients.
    Snydman DR
    Transplant Proc; 1993 Oct; 25(5 Suppl 4):25-6. PubMed ID: 8212304
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of life-threatening infections in renal transplant recipients with high-dose intravenous human IgG.
    Condie RM; Hall BL; Howard RJ; Fryd D; Simmons RL; Najarian JS
    Transplant Proc; 1979 Mar; 11(1):66-8. PubMed ID: 222019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune globulin therapy in allogeneic bone marrow transplant: a critical review.
    Guglielmo BJ; Wong-Beringer A; Linker CA
    Bone Marrow Transplant; 1994 May; 13(5):499-510. PubMed ID: 8054903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of human cytomegalovirus DNA by a new capture hybrid polymerase chain reaction enzyme-linked immunosorbent assay in plasma and peripheral blood mononuclear cells of bone marrow transplant recipients.
    Ziyaeyan M; Sabahi F; Alborzi A; Ramzi M; Mahboudi F; Pourabbas B; Kadivar M
    Exp Clin Transplant; 2008 Dec; 6(4):294-300. PubMed ID: 19338492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.